Skip to main content
Premium Trial:

Request an Annual Quote

BGI Launches George Church Institute of Regenesis

NEW YORK (GenomeWeb) – BGI said today that is has launched the George Church Institute of Regenesis, which plans to focus on synthetic biology technologies and applications, and will collaborate with Church, a professor of genetics at Harvard Medical School.

Church, a longtime advisor to BGI, will be chief scientist of the institute that bears his name, which is co-located with the China National GeneBank in Shenzhen.

BGI said it has "made a strong commitment to support research" directed by Church, both in China and in the US. The plan is to launch a series of projects, starting in January 2018.

The collaboration will initially focus on the development of technologies in high-density DNA storage, biomanufacturing of natural products, and genome editing for medicine.

Xun Xu, director of BGI Research, said in a statement that synthetic biology is a major effort that follows the wide use of genome sequencing. The new collaboration "will bring top resources and talent together to overcome current bottleneck issues and further improve the technology," he said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more